Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition and application thereof

A composition and drug technology applied in the field of medicine to achieve the effects of reducing infiltration, increasing conception rate, and reducing hypertrophy

Active Publication Date: 2022-08-05
CHINA PHARM UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the main drugs for the treatment of primary dysmenorrhea are non-steroidal anti-inflammatory drugs, but their inefficiency is 20%-30%, so there is an urgent need to find a low-risk, effective drug to relieve dysmenorrhea

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition and application thereof
  • Pharmaceutical composition and application thereof
  • Pharmaceutical composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] A pharmaceutical composition is composed of 1,6-diphosphate fructose trisodium salt and nicotinamide mononucleotide NMN; the moles of 1,6-diphosphate fructose trisodium salt FDP and nicotinamide mononucleotide NMN are The ratio is 1:1.

Embodiment 2

[0038] A pharmaceutical composition is composed of 1,6-diphosphate fructose trisodium salt and nicotinamide mononucleotide NMN; the moles of 1,6-diphosphate fructose trisodium salt FDP and nicotinamide mononucleotide NMN are The ratio is 1:2.

Embodiment 3

[0040] A pharmaceutical composition is composed of 1,6-diphosphate fructose trisodium salt and nicotinamide mononucleotide NMN; the moles of 1,6-diphosphate fructose trisodium salt FDP and nicotinamide mononucleotide NMN are The ratio is 1:3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition and application thereof, and the pharmaceutical composition is composed of 1, 6-fructose diphosphate (FDP) or a pharmaceutically acceptable salt thereof, and nicotinamide mononucleotide NMN / nicotinamide adenine dinucleotide NAD + or a pharmaceutically acceptable salt thereof. The invention also discloses application of the compound in preparation of medicines for preventing and / or treating primary dysmenorrhea and infertility. The invention discloses an action mechanism of FDP and NMN / NAD < + > combined administration in treating a mouse primary dysmenorrhea model, and finds that the FDP and NMN / NAD < + > combined administration has a better curative effect than FDP or NMN / NAD < + > independent administration, and can obviously reduce the writhing reaction frequency of a female mouse, increase the incubation period of the writhing reaction, reduce the gene expression level of COX-2 and PGF2alpha in uterine tissues, increase the gene expression level of PGE2, and improve the mouse primary dysmenorrhea treatment effect. Infiltration of inflammatory cells is reduced, and uterine tissue edema and inflammatory pathology degree are improved; in addition, combined administration of FDP and NMN / NAD + can significantly increase the pregnancy rate of female mice compared with independent administration of FDP or NMN / NAD +.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a pharmaceutical composition and use thereof. The pharmaceutical composition is composed of fructose 1,6-diphosphate (FDP) or a pharmaceutically acceptable salt thereof and nicotinamide mononucleotide NMN / nicotinamide adenine dinucleotide NAD + Or its pharmaceutically acceptable salt composition; and its preparation in the prevention and / or treatment of primary dysmenorrhea, infertility medicine application. Background technique [0002] Primary dysmenorrhea (PD) refers to the cramping pain in the lower abdomen of women during menstruation without obvious pelvic organic lesions, accompanied by low back and leg pain, diarrhea, nervousness, fatigue, loss of appetite, and nausea. Symptoms such as vomiting. At present, the drugs for primary dysmenorrhea are mainly non-steroidal anti-inflammatory drugs, but their inefficiency is 20%-30%. Therefore, there is an urgent need to find a l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/706A61K31/7084A61K31/7004A61P15/00A61P29/00A61P15/08
CPCA61K31/706A61K31/7084A61K31/7004A61P15/00A61P29/00A61P15/08A61K2300/00Y02A50/30
Inventor 庞涛魏大厦黄丽华管昕郑月钦
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com